NEW YORK (GenomeWeb News) — Microbial genomics company OpGen today said it has received an undisclosed investment from In-Q-Tel, a non-profit launched by the US Central Intelligence Agency that invests in technologies "of importance to the intelligence community."
 
In a statement describing the investment, In-Q-Tel said that OpGen’s microbial genome-analysis technology will “significantly improve the user's ability to analyze organisms.”
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.